Drug metabolite profiling and identification by high-resolution mass spectrometry |
| |
Authors: | Zhu Mingshe Zhang Haiying Humphreys W Griffith |
| |
Affiliation: | Bristol-Myers Squibb Pharmaceutical Company, Princeton, New Jersey 08543, USA. |
| |
Abstract: | Mass spectrometry plays a key role in drug metabolite identification, an integral part of drug discovery and development. The development of high-resolution (HR) MS instrumentation with improved accuracy and stability, along with new data processing techniques, has improved the quality and productivity of metabolite identification processes. In this minireview, HR-MS-based targeted and non-targeted acquisition methods and data mining techniques (e.g. mass defect, product ion, and isotope pattern filters and background subtraction) that facilitate metabolite identification are examined. Methods are presented that enable multiple metabolite identification tasks with a single LC/HR-MS platform and/or analysis. Also, application of HR-MS-based strategies to key metabolite identification activities and future developments in the field are discussed. |
| |
Keywords: | Cytochrome P450 Drug Metabolism Mass Spectrometry (MS) Metabolism Microsomes High-resolution Mass Spectrometry Metabolite Identification |
本文献已被 PubMed 等数据库收录! |
|